Publicaciones en las que colabora con Cristina Alenda González (28)

2021

  1. Clyta-daao chimeric enzyme bound to magnetic nanoparticles. A new therapeutical approach for cancer patients?

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-24

2020

  1. CLyta-DAAO, free and immobilized in magnetic nanoparticles, induces cell death in human cancer cells

    Biomolecules, Vol. 10, Núm. 2

  2. Cell death mechanisms induced by CLytA‐DAAO chimeric enzyme in human tumor cell lines

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-25

  3. Clinical and Pathological Characterization of Lynch-Like Syndrome

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 2, pp. 368-374.e1

  4. Risk of cancer in family members of patients with lynch-like syndrome

    Cancers, Vol. 12, Núm. 8, pp. 1-12

2019

  1. Correction: Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3 (PLoS One (2019) 14:2 (e0212581) DOI: 10.1371/journal.pone.0212581)

    PLoS ONE

  2. Radiotherapy resistance acquisition in glioblastoma. Role of SOCS1 and SOCS3

    PLoS ONE, Vol. 14, Núm. 2

2018

  1. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy

    PLoS ONE, Vol. 13, Núm. 9

2017

  1. Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives

    Gastroenterology, Vol. 153, Núm. 1, pp. 106-112.e2

  2. KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia

    PLoS ONE, Vol. 12, Núm. 9

  3. Lack of cytomegalovirus detection in human glioma

    Virology Journal, Vol. 14, Núm. 1

2016

  1. The heritability and patterns of DNA methylation in normal human colorectum

    Human molecular genetics, Vol. 25, Núm. 12, pp. 2600-2611

2015

  1. Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer

    Journal of Medical Genetics, Vol. 52, Núm. 7, pp. 498-502

2014

  1. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database

    Nature Genetics, Vol. 46, Núm. 2, pp. 107-115

  2. New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis

    Human Molecular Genetics, Vol. 23, Núm. 13, pp. 3506-3512

  3. Prevalence and characteristics of mutyh-associated polyposis in patients with multiple adenomatous and serrated polyps

    Clinical Cancer Research, Vol. 20, Núm. 5, pp. 1158-1168

2013

  1. Clinical subtypes and molecular characteristics of serrated polyposis syndrome

    Clinical Gastroenterology and Hepatology, Vol. 11, Núm. 6, pp. 705-711

  2. Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers

    PLoS ONE, Vol. 8, Núm. 11

  3. Risk of cancer in cases of suspected lynch syndrome without germline mutation

    Gastroenterology, Vol. 144, Núm. 5

2012

  1. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer

    Gut, Vol. 61, Núm. 6, pp. 865-872